These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29704427)

  • 21. ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis.
    Chen C; Gupta P; Parashar D; Nair GG; George J; Geethadevi A; Wang W; Tsaih SW; Bradley W; Ramchandran R; Rader JS; Chaluvally-Raghavan P; Pradeep S
    Oncogene; 2020 Apr; 39(14):2921-2933. PubMed ID: 32029900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
    Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
    J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PLAC1: biology and potential application in cancer immunotherapy.
    Mahmoudian J; Ghods R; Nazari M; Jeddi-Tehrani M; Ghahremani MH; Ghaffari-Tabrizi-Wizsy N; Ostad SN; Zarnani AH
    Cancer Immunol Immunother; 2019 Jul; 68(7):1039-1058. PubMed ID: 31165204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study.
    Wang MC; Jiao M; Wu T; Jing L; Cui J; Guo H; Tian T; Ruan ZP; Wei YC; Jiang LL; Sun HF; Huang LX; Nan KJ; Li CL
    Oncotarget; 2016 Feb; 7(8):9586-99. PubMed ID: 26840020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway.
    Wang SC; Lin XL; Wang HY; Qin YJ; Chen L; Li J; Jia JS; Shen HF; Yang S; Xie RY; Wei F; Gao F; Rong XX; Yang J; Zhao WT; Zhang TT; Shi JW; Yao KT; Luo WR; Sun Y; Xiao D
    Oncotarget; 2015 Nov; 6(34):36713-30. PubMed ID: 26452025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
    Liu F; Zhang H; Song H
    Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PI(3,4)P
    Fukumoto M; Ijuin T; Takenawa T
    Cancer Sci; 2017 May; 108(5):941-951. PubMed ID: 28247964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different expression levels of DLK1 inversely modulate the oncogenic potential of human MDA-MB-231 breast cancer cells through inhibition of NOTCH1 signaling.
    Nueda ML; Naranjo AI; Baladrón V; Laborda J
    FASEB J; 2017 Aug; 31(8):3484-3496. PubMed ID: 28461338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer.
    Liu W; Zhai M; Wu Z; Qi Y; Wu Y; Dai C; Sun M; Li L; Gao Y
    Amino Acids; 2012 Jun; 42(6):2257-65. PubMed ID: 21710262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer.
    Li T; Lu H; Mukherjee D; Lahiri SK; Shen C; Yu L; Zhao J
    Oncotarget; 2015 Aug; 6(25):21428-42. PubMed ID: 26025929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma.
    Yin Y; Zhu X; Huang S; Zheng J; Zhang M; Kong W; Chen Q; Zhang Y; Chen X; Lin K; Ouyang X
    Tumour Biol; 2017 Jun; 39(6):1010428317699131. PubMed ID: 28618924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis].
    Wang Z; Liu Q; Chen Q; Zhu R; Zhu HG
    Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):333-8. PubMed ID: 16834906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.
    Kuang J; Li L; Guo L; Su Y; Wang Y; Xu Y; Wang X; Meng S; Lei L; Xu L; Shao G
    J Exp Clin Cancer Res; 2016 Jun; 35(1):88. PubMed ID: 27259701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN.
    Zhang YQ; Liang YK; Wu Y; Chen M; Chen WL; Li RH; Zeng YZ; Huang WH; Wu JD; Zeng D; Gao WL; Chen CF; Lin HY; Yang RQ; Zhu JW; Liu WL; Bai JW; Wei M; Wei XL; Zhang GJ
    Cell Death Dis; 2021 May; 12(6):502. PubMed ID: 34006834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
    Liu C; Zhou S; Ke CS; Li NP; Wu RL
    Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis.
    Yuan H; Wang X; Shi C; Jin L; Hu J; Zhang A; Li J; Vijayendra N; Doodala V; Weiss S; Tang Y; Weiner LM; Glazer RI
    Sci Rep; 2018 Apr; 8(1):5717. PubMed ID: 29632317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines.
    Fragni M; Bonini SA; Bettinsoli P; Bodei S; Generali D; Bottini A; Spano PF; Memo M; Sigala S
    Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):529-38. PubMed ID: 26905520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.
    Chen J; Chang H; Peng X; Gu Y; Yi L; Zhang Q; Zhu J; Mi M
    Sci Rep; 2016 Jun; 6():28858. PubMed ID: 27345219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.